相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The potential role of Akt phosphorylation in human cancers
J. Cicenas
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)
Sar1 GTPase Activity Is Regulated by Membrane Curvature
Michael G. Hanna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer
M. Nicos et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
The Aurora kinase inhibitors in cancer research and therapy
Jonas Cicenas
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Multi-kinase inhibitors, AURKs and cancer
Jonas Cicenas et al.
MEDICAL ONCOLOGY (2016)
The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer
Sunny Guin et al.
ACTA PHARMACOLOGICA SINICA (2015)
Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma
Dirk Schadendorf et al.
EUROPEAN JOURNAL OF CANCER (2015)
Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma
Soo Young Kim et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
Georgina V. Long et al.
LANCET (2015)
Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial
Jean Jacques Grob et al.
LANCET ONCOLOGY (2015)
Genetic analysis of the 'uveal melanoma' C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line
Xiaoxing Yu et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies
Francesco Spagnolo et al.
ONCOTARGETS AND THERAPY (2015)
Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies
Douglas B. Johnson et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Increased expression of ARF GTPases in prostate cancer tissue
Claire Morgan et al.
SPRINGERPLUS (2015)
Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer
Marta Schirripa et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2015)
Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases
Chen Mao et al.
SCIENTIFIC REPORTS (2015)
Roscovitine in cancer and other diseases
Jonas Cicenas et al.
ANNALS OF TRANSLATIONAL MEDICINE (2015)
Structures of Ras superfamily effector complexes: What have we learnt in two decades?
Helen R. Mott et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Impact of BRAF mutation status in the prognosis of cutaneous melanoma: an area of ongoing research
Parisha Bhatia et al.
ANNALS OF TRANSLATIONAL MEDICINE (2015)
The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis
Christina Therkildsen et al.
ACTA ONCOLOGICA (2014)
BRAF Mutation Predicts for Poor Outcomes After Metastasectomy in Patients With Metastatic Colorectal Cancer
Rona Yaeger et al.
CANCER (2014)
Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma
Devalingam Mahalingam et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
Grant A. McArthur et al.
LANCET ONCOLOGY (2014)
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)
Andrea Casadei Gardini et al.
PLOS ONE (2014)
Colorectal cancer: From prevention to personalized medicine
Gemma Binefa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Highlights of the Latest Advances in Research on CDK Inhibitors
Jonas Cicenas et al.
CANCERS (2014)
The Multifunctional Protein Kinase C-ε in Cancer Development and Progression
Kirti Jain et al.
CANCERS (2014)
Mitochondrial trafficking in neurons and the role of the Miro family of GTPase proteins
Nicol Birsa et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Signaling networks of Rho GTPases in cell motility
Samer Hanna et al.
CELLULAR SIGNALLING (2013)
A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis
Cheryl Eifert et al.
GENES CHROMOSOMES & CANCER (2013)
Global estimates of cancer prevalence for 27 sites in the adult population in 2008
Freddie Bray et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Phase III Trial of Carboplatin and Paclitaxel With or Without Sorafenib in Metastatic Melanoma
Keith T. Flaherty et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Bevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation
Filip Janku et al.
TARGETED ONCOLOGY (2013)
Toward a molecular classification of colorectal cancer: the role of microsatellite instability status
Karl Heinimann
FRONTIERS IN ONCOLOGY (2013)
Toward a molecular classification of colorectal cancer: the role of BRAF
Alexandra Thiel et al.
FRONTIERS IN ONCOLOGY (2013)
NRAS mutation status is an independent prognostic factor in metastatic melanoma
John A. Jakob et al.
CANCER (2012)
Melanoma: from mutations to medicine
Hensin Tsao et al.
GENES & DEVELOPMENT (2012)
The Ras protein superfamily: Evolutionary tree and role of conserved amino acids
Ana Maria Rojas et al.
JOURNAL OF CELL BIOLOGY (2012)
Correlation of NRAS Mutations With Clinical Response to High-dose IL-2 in Patients With Advanced Melanoma
Richard W. Joseph et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Axel Hauschild et al.
LANCET (2012)
RAS mutations and the development of secondary tumours in patients given BRAF inhibitors
Sharan Prakash Sharma
LANCET ONCOLOGY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
The GDI-like solubilizing factor PDEδ sustains the spatial organization and signalling of Ras family proteins
Anchal Chandra et al.
NATURE CELL BIOLOGY (2012)
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
Sergey I. Nikolaev et al.
NATURE GENETICS (2012)
Vemurafenib: the first drug approved for BRAF-mutant cancer
Gideon Bollag et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
The Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-Analysis
Gholamreza Safaee Ardekani et al.
PLOS ONE (2012)
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies
T. Eisen et al.
BRITISH JOURNAL OF CANCER (2011)
RAN GTPase as a Target for Cancer Therapy: Ran Binding Proteins
K. J. Doherty et al.
CURRENT MOLECULAR MEDICINE (2011)
The CDK inhibitors in cancer research and therapy
Jonas Cicenas et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Fine Tuning of Protein Kinase C (PKC) Isoforms in Cancer: Shortening the Distance from the Laboratory to the Bedside
R. Bosco et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2011)
Role of Rab GTPases in Membrane Traffic and Cell Physiology
Alex H. Hutagalung et al.
PHYSIOLOGICAL REVIEWS (2011)
Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma
Bianca Devitt et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
ProKinO: An Ontology for Integrative Analysis of Protein Kinases in Cancer
Gurinder Gosal et al.
PLOS ONE (2011)
RAF protein-serine/threonine kinases: Structure and regulation
Robert Roskoski
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
A Mouse Model of Melanoma Driven by Oncogenic KRAS
Carla Milagre et al.
CANCER RESEARCH (2010)
NRAS Mutations Are Rare in Colorectal Cancer
Natsumi Irahara et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2010)
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
Wendy De Roock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Arnaud D. Roth et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
ADP-Ribosylation Factors Modulate the Cell Surface Transport of G Protein-Coupled Receptors
Chunmin Dong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation
Ramin Nazarian et al.
NATURE (2010)
Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases
Ravi K. Amaravadi et al.
CLINICAL CANCER RESEARCH (2009)
Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma
Axel Hauschild et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Rab GTPases as coordinators of vesicle traffic
Harald Stenmark
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status
Nadine Lukan et al.
ONCOLOGY (2009)
Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs
Ilaria Cascone et al.
EMBO JOURNAL (2008)
Rho GTPases in cancer cell biology
Francisco M. Vega et al.
FEBS LETTERS (2008)
Role of Rho GTPases in breast cancer
Yong Tang et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
The RanGTP gradient - a GPS for the mitotic spindle
Petr Kalab et al.
JOURNAL OF CELL SCIENCE (2008)
Differential oncogenic potential of activated RAS isoforms in melanocytes
T. Whitwam et al.
ONCOGENE (2007)
The potential role of the EGFR/ERBB2 heterodimer in breast cancer
Jonas Cicenas
EXPERT OPINION ON THERAPEUTIC PATENTS (2007)
Phosphorylation of tyrosine 1248-ERBB2 measured by chemiluminescence-linked immunoassay is an independent predictor of poor prognosis in primary breast cancer patients
J Cicenas et al.
EUROPEAN JOURNAL OF CANCER (2006)
Localization and function of Arf family GTPases
JG Donaldson et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
The Ras superfamily at a glance
K Wennerberg et al.
JOURNAL OF CELL SCIENCE (2005)
Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2
J Cicenas et al.
BREAST CANCER RESEARCH (2005)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
BRAF mutations are common somatic events in melanocytic nevi
R Kumar et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Early diagnosis of cutaneous melanoma - Revisiting the ABCD criteria
NR Abbasi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Structural principles for the multispecificity of small GTP-binding proteins
V Biou et al.
BIOCHEMISTRY (2004)
Multiple roles for Arf6: Sorting, structuring, and signaling at the plasma membrane
JG Donaldson
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
High frequency of BRAF mutations in nevi
PM Pollock et al.
NATURE GENETICS (2003)
Ran in the spindle checkpoint: a new function for a versatile GTPase
HY Li et al.
TRENDS IN CELL BIOLOGY (2003)
Rho GTPases in cell biology
S Etienne-Manneville et al.
NATURE (2002)
Arf, Arl, Arp and Sar proteins: a family of GTP-binding proteins with a structural device for 'front-back' communication
S Pasqualato et al.
EMBO REPORTS (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Signal transduction - The guanine nucleotide-binding switch in three dimensions
IR Vetter et al.
SCIENCE (2001)
分享论文
